GBC News

18 nominees vie for Greater Baltimore Committee’s 2009 Bioscience Awards on March 12

Posted: February 25, 2009

More than 150 leaders from Maryland's bioscience industry and research community will attend a breakfast at the Renaissance Baltimore Harborplace Hotel to honor winners of the Greater Baltimore Committee’s 2009 Bioscience Awards.

This is the fourth annual awards event presented by the Greater Baltimore Committee, the region’s most prominent organization of business and civic leaders, to recognize outstanding achievements in Maryland’s bioscience industry. The Greater Baltimore Committee has made support for the emerging bioscience industry in the region one of its top long-term priorities.

Award winners will be selected from 18 nominations submitted by businesses, bioscience advocates, higher education institutions and government officials.

Awards will be presented in the following categories: Best New Product or Progress Award, Leadership in Bioscience Award, Entrepreneurial Spirit Award, and President's Award.

Nominees for this year’s awards are:

Best New Product or Progress Award

Kris Appel, founder and president, Encore Path, Inc.
Kerrie L. Brady, COO, Arcion Therapeutics Inc., and CEO, Traxion Therapeutics, Inc.
Dr. Kimberly Brown, CEO, Amethyst Technologies, LLC
Dr. George Falus, president, Biomedica Management Corporation
Fred E. Festa, chairman, president and CEO, W.R. Grace & Company
Dr. C. Randal Mills, president and CEO, Osiris Therapeutics, Inc.
Dr. Bruce Thompson, chairman of the board and president, Clinical Trials and Surveys Corp. (C-TASC)

Leadership in Bioscience Award

Dr. Claire M. Fraser-Liggett, professor of medicine, director, Institute for Genome Sciences, University of Maryland School of Medicine
Vinita Gupta, president, Lupin Pharmaceuticals, Inc.
Kären Olsen, CEO, BioMarker Strategies, LLC

Entrepreneurial Spirit Award

Dr. Atul Bedi, co-founder, IATRICa, Inc.
Kerrie L. Brady, COO, Arcion Therapeutics Inc., and CEO, Traxion Therapeutics, Inc.
Dr. Marco Chacon, president and CEO, Paragon Bioservices, Inc.
Dr. Suzanne Sysko Clough, founder and chief medical officer, WellDoc Communications, Inc.
Kären Olsen, CEO, BioMarker Strategies, LLC

President’s Award

Wesley D. Blakeslee, executive director, Johns Hopkins Technology Transfer
Ellen J. Hemmerly, executive director, UMBC Research Park Corporation and founder, ACTiVATE®
Kathleen O’Donnell Weiss, executive director, The BioTechnical Institute of Maryland, Inc.

Program sponsor for the event is DLA Piper. Patron sponsors are Katz Abosch and PhRMA. Media sponsors are The Daily Record and The Gazette of Politics and Business.

To register to attend the event, click here.